<scp>DKK1</scp> drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with <scp>anti‐DKK1</scp> therapeutic <scp>DKN</scp> ‐01-Reference-Cited by-同舟云学术

DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN ‐01

Published:2022-09-15 Issue:1 Volume:43 Page:208-220
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Jarman Edward J.¹^ORCID,Horcas‐Lopez Marta²,Waddell Scott H.¹^ORCID,MacMaster Stephanie¹,Gournopanos Konstantinos¹,Soong Daniel Y. H.²,Musialik Kamila I.¹,Tsokkou Panagiota¹,Ng Minn‐E¹,Cambridge William A.¹³,Wilson David H.¹,Kagey Michael H.⁴,Newman Walter⁴,Pollard Jeffrey W.²^ORCID,Boulter Luke¹^ORCID

Affiliation:

1. MRC Human Genetics Unit Institute of Genetics and Cancer, University of Edinburgh Edinburgh UK

2. MRC Centre for Reproductive Health Queen's Medical Research Institute, The University of Edinburgh Edinburgh UK

3. Department of Clinical Surgery University of Edinburgh, Little France Crescent Edinburgh UK

4. Leap Therapeutics Cambridge Massachusetts USA

Funder

Cancer Research UK

Royal College of Surgeons of Edinburgh

Wellcome Trust

Publisher

Wiley

Subject